ATF2 and prostate neoplasm: Analysis of samples from normal prostate tissue, benign prostatic hyperplasia and prostate cancer revealed that phosphorylated ATF2 is overexpressed in benign prostatic hyperplasia and, much higher, in prostate tumors [26].